Antioxidant defences in cybrids harboring mtDNA mutations associated with Leber's hereditary optic neuropathy

被引:85
作者
Floreani, M
Napoli, E
Martinuzzi, A
Pantano, G
De Riva, V
Trevisan, R
Bisetto, E
Valente, L
Carelli, V
Dabbeni-Sala, F
机构
[1] Conegliano Res Ctr, E Medea Sci Inst, I-31015 Conegliano, TV, Italy
[2] Univ Padua, Pharmacol Sect, Dept Pharmacol & Anesthesiol, I-35100 Padua, Italy
[3] Univ Bologna, Dept Neurol Sci, I-40126 Bologna, Italy
关键词
antioxidant enzymes; galactose medium; GSH and GSSG; Leber's hereditary optic neuropathy (LHON) cybrids; oxidative stress;
D O I
10.1111/j.1742-4658.2004.04542.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oxidative stress and imbalance between free radical generation and detoxification may play a pivotal role in the pathogenesis of Leber's hereditary optic neuropathy (LHON). Mitochondria, carrying the homoplasmic 11778/ND4, 3460/ND1 and 14484/ND6 mtDNA point mutations associated with LHON, were used to generate osteosarcoma-derived cybrids. Enhanced mitochondrial production of reactive oxygen species has recently been demonstrated in these cybrids [Beretta S, Mattavelli L, Sala G, Tremolizzo L, Schapira AHV, Martinuzzi A, Carelli V & Ferrarese C (2004) Brain 127, 2183-2192]. The aim of this study was to characterize the antioxidant defences of these LHON-affected cells. The activities of glutathione peroxidase (GPx), glutathione reductase (GR) superoxide dismutases, (SOD) and catalase, and the amounts of glutathione (GSH) and oxidized glutathione (GSSG) were measured in cybrids cultured both in glucose-rich medium and galactose-rich medium. The latter is known to cause oxidative stress and to trigger apoptotic death in these cells. In spite of reduced SOD activities in all LHON cybrids, and of low GPx and GR activities in cells with the most severe 3460/ND1 and 11778/ND4 mutations, GSH and GSSG content were not significantly modified in LHON cybrids cultured in glucose medium. In contrast, in galactose, GSSG concentrations increased significantly in all cells, indicating severe oxidative stress, whereas GR and MnSOD activities further decreased in all LHON cybrids. These data suggest that, in cells carrying LHON mutations, there is a decrease in antioxidant defences, which is especially evident in cells with mutations associated with the most severe clinical phenotype. This is magnified by stressful conditions such as exposure to galactose.
引用
收藏
页码:1124 / 1135
页数:12
相关论文
共 49 条
[1]  
AEBI H, 1984, METHOD ENZYMOL, V105, P121
[2]  
ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548
[3]   GLUCOSE REGULATION OF HYDROPEROXIDE METABOLISM IN RAT INTESTINAL-CELLS - STIMULATION OF REDUCED NICOTINAMIDE ADENINE-DINUCLEOTIDE PHOSPHATE SUPPLY [J].
AW, TY ;
RHOADS, CA .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (06) :2426-2434
[4]   Titrating the effects of mitochondrial complex I impairment in the cell physiology [J].
Barrientos, A ;
Moraes, CT .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (23) :16188-16197
[5]   Leber hereditary optic neuropathy mtDNA mutations disrupt glutamate transport in cybrid cell lines [J].
Beretta, S ;
Mattavelli, L ;
Sala, G ;
Tremolizzo, L ;
Schapira, AHV ;
Martinuzzi, A ;
Carelli, V ;
Ferrarese, C .
BRAIN, 2004, 127 :2183-2192
[6]   The enigmatic relationship between mitochondrial dysfunction and Leber's hereditary optic neuropathy [J].
Brown, MD .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1999, 165 (01) :1-5
[7]   Functional analysis of lymphoblast and cybrid mitochondria containing the 3460, 11778, or 14484 Leber's hereditary optic neuropathy mitochondrial DNA mutation [J].
Brown, MD ;
Trounce, IA ;
Jun, AS ;
Allen, JC ;
Wallace, DC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (51) :39831-39836
[8]   Respiratory function in cybrid cell lines carrying European mtDNA haplogroups: implications for Leber's hereditary optic neuropathy [J].
Carelli, V ;
Vergani, L ;
Bernazzi, B ;
Zampieron, C ;
Bucchi, L ;
Valentino, ML ;
Rengo, C ;
Torroni, A ;
Martinuzzi, A .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2002, 1588 (01) :7-14
[9]  
Carelli V, 1999, ANN NEUROL, V45, P320, DOI 10.1002/1531-8249(199903)45:3<320::AID-ANA7>3.3.CO
[10]  
2-C